Rachel Reeves (pictured) now looks to have already lost around half her £9.9bn of fiscal ‘headroom’ due to rising borrowing costs.Read More

You might also be interested in reading AptarGroup projects double-digit EPS growth in 2025 backed by pharma and closures segments.